Are you thinking about selling now? Lexicon Pharmaceuticals Inc (LXRX) Stock
Leerink Partners raised the price target for the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) stock to “an Outperform”. The rating was released on April 30, 2024, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $10. The stock was upgraded by JP Morgan, who disclosed […]
Is Lexicon Pharmaceuticals Inc (LXRX) Stock A Better Investment Than Its Rivals?
Leerink Partners raised the price target for the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) stock to “an Outperform”. The rating was released on April 30, 2024, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $10. The stock was upgraded by JP Morgan, who disclosed […]
What do you think? Take A Moment To Read: Lexicon Pharmaceuticals Inc (LXRX) Stock
Jefferies raised the price target for the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) stock to “a Hold”. The rating was released on March 07, 2023, according to finviz. The research report from JP Morgan has upgraded the stock from Underweight to Neutral, with a price target set at $7. The stock was downgraded by Wedbush, who disclosed […]
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) stock is trading -58.30 percent below its 52-week high
Jefferies raised the price target for the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) stock to “a Hold”. The rating was released on March 07, 2023, according to finviz. The research report from JP Morgan has upgraded the stock from Underweight to Neutral, with a price target set at $7. The stock was downgraded by Wedbush, who disclosed […]
Why Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) Stock rose 37.50% in Last Six Months?
Jefferies raised the price target for the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) stock to “a Hold”. The rating was released on March 07, 2023, according to finviz. The research report from JP Morgan has upgraded the stock from Underweight to Neutral, with a price target set at $7. The stock was downgraded by Wedbush, who disclosed […]
Yummy or too sour? Lexicon Pharmaceuticals Inc (LXRX) Stock
Jefferies raised the price target for the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) stock to “a Hold”. The rating was released on March 07, 2023, according to finviz. The research report from JP Morgan has upgraded the stock from Underweight to Neutral, with a price target set at $7. The stock was downgraded by Wedbush, who disclosed […]
Jefferies Sets Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) Stock to “a Hold”
Jefferies raised the price target for the Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) stock to “a Hold”. The rating was released on March 07, 2023, according to finviz. The research report from JP Morgan has upgraded the stock from Underweight to Neutral, with a price target set at $7. The stock was downgraded by Wedbush, who disclosed […]
